Biological Markers in Colon Cancer Outcomes
Author Information
Author(s): Nanni O, Volpi A, Frassineti G L, De Paola F, Granato A M, Dubini A, Zoli W, Scarpi E, Turci D, Oliverio G, Gambi A, Amadori D
Primary Institution: Istituto Oncologico Romagnolo
Hypothesis
Can biological markers predict clinical outcomes in colon cancer patients treated with 5-FU-containing regimens?
Conclusion
The study found that biological markers like MVD, VEGF, and TS expression do not significantly impact the clinical outcomes of colon cancer patients.
Supporting Evidence
- Age, gender, and Dukes' stage impacted disease-free survival.
- Histological grade and Dukes' stage influenced overall survival.
- No biological marker was found to indicate better or worse disease-free survival.
Takeaway
Researchers looked at different markers in colon cancer to see if they could help predict how well patients would do, but they found that these markers didn't really help.
Methodology
The study analyzed colon cancer tissue from 263 patients for various biological markers and their impact on disease-free and overall survival.
Limitations
The study had a small sample size and focused on specific groups of markers, which may limit the generalizability of the findings.
Participant Demographics
Median age was 60 years, with a balanced distribution of males and females, and most patients had Dukes' Stage B or C tumors.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website